Cited by 14Restless Legs Syndrome ResearchParkinson's Disease Mechanisms and TreatmentsSleep and related disorders

Sternberg working memory performance following treatment with pramipexole in patients with moderate-to-severe restless legs syndrome

Open access
Jung, Ki-Young, Kim, Sung Min, Song, Jin-Young, Lee, Byeong Uk, Lee, Chany, Lee, Sang Kun, Koo, Yong Seo, Cho, Yong Won +2 more·2015·Sleep Medicine

Abstract

Objectives We recently reported that the P300 amplitude related to the Sternberg working memory (WM) task was significantly lower in drug-naïve severe restless legs syndrome (RLS) patients than controls. Here, we evaluated the effects of pramipexole on the Sternberg WM task performance by event-related potential (ERP) study.Methods Thirteen drug-naïve RLS patients (52.0 ± 9.48 years) were enrolled in the study. Pramipexole was administered over a period of 12 weeks every night 1 h before bedtime. Two ERP studies were carried out: the first was performed just before giving the first dose of pramipexole and the second was conducted at 12-16 weeks after commencement of pramipexole administration. P300 amplitudes and reaction times were compared before and after treatment considering brain regions and memory load as within-subject factors. Clinical and sleep-related variables were correlated with P300 amplitude.Results After treatment with pramipexole, the International RLS Severity Scale (IRLS) score was significantly decreased. Sleep quality and depression were also significantly improved. Omission error was significantly reduced without significant change of commission error. Reaction time was significantly shortened, regardless of memory load size, following treatment with pramipexole. Parietal P300 amplitude was significantly increased after treatment with pramipexole for all memory load sizes. Increase of frontal P300 amplitude was significantly correlated with improvement of sleep duration, IRLS, Insomnia Severity Index, and Pittsburgh Sleep Quality Index score.Conclusion Our study suggested that pramipexole improves WM performance in patients with RLS in addition to improving RLS symptoms, sleep disturbance, and depression.

Integrity signals

Registry

Crossref · 10.1016/j.sleep.2014.10.025

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pramipexole has been shown to improve sustained attention, particularly in baseline low performers.

    “Finally, the D3 agonist pramipexole has recently been shown to improve sustained attention, particularly in baseline low performers120.”

    From Paying attention to attention in depression (2019) · cites this paper as [120]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jung, K.-Y., Kim, S. M., Song, J.-Y., Lee, B. U., Lee, C., Lee, S. K., Koo, Y. S., Cho, Y. W., Choi, J. W., & Kim, K. H.
Affiliations
  • Seoul National University (KR)
  • Korea University Medical Center (KR)
  • Hanyang University (KR)
  • Keimyung University Dongsan Medical Center (KR)
  • Yonsei University (KR)
Corresponding author
  • Jung, Ki-Young
  • Kim, Kyung Hwan
Venue
Sleep Medicine
Publisher
Elsevier BV
Published
2015-06
Volume
16
Issue
6
Pages
703-708
ISSN
1389-9457 (ISSN-L)
OpenAlex
W2084729711
Cited by
14
References
35
Citations by year
2026: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2015: 1
FWCI
1.05
Type
journal article
Language
en
Open access
Locations
  • Sleep Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • KUMeL Repository (Keimyung University) (submittedVersion, cc-by-nc-nd)
Funders
  • National Research Foundation of Korea (20110029740)
  • Korea Environmental Industry and Technology Institute (RE201206020)
Topics
  • Health Sciences › Medicine › Epidemiology › Restless Legs Syndrome Research
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Keywords
restless legs syndrome, pramipexole, P300 amplitude, event-related potentials, sleep disorders, insomnia, depression, reaction time, memory load
MeSH terms
Pramipexole, Adult, Depression, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Male, Memory, Short-Term, Middle Aged, Neuropsychological Tests, Reaction Time, Restless Legs Syndrome, Event-Related Potentials, P300, Benzothiazoles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review